Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cleared is a digital health company that provides comprehensive telehealth services for the diagnosis and treatment of allergies, asthma, and immunology-related conditions. The company's platform enables patients to conduct at-home allergy testing and consult with licensed clinicians to receive personalized treatment plans. Their primary offering includes sublingual immunotherapy (allergy drops), which serves as a non-invasive alternative to traditional allergy shots, alongside prescriptions for nasal sprays and asthma inhalers. By leveraging a direct-to-consumer model, Cleared aims to make specialized immunology care more affordable and convenient for patients across the United States. In early 2022, the company was acquired by Wisp, a leading sexual health telehealth provider, to expand its portfolio into chronic condition management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cleared.